1. Stocks
    2. /
  2. Clarity Pharmaceuticals (ASX: CU6)
    3. /

Clarity Pharmaceuticals (ASX: CU6) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clarity Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clarity Pharmaceuticals (ASX: CU6)
    Latest News

    Close-up photo of man's hands holding silver platter with coins and young plant growing out of pile of money
    Broker Notes

    Wilsons Advisory names four small-cap investment ideas and one speccy stock

    | Cameron England

    Looking for value in the mid-market? Look no further.

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Healthcare Shares

    Which ASX 300 share is surging 9% on big news?

    | James Mickleboro

    This share is rising on exciting news. Let's see what's happening.

    Read more »

    An old-fashioned panel of judges each holding a card with the number 10
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a happy end to the trading week this Friday.

    Read more »

    Girl with painted hands.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a solid performance from the Australian market this Tuesday.

    Read more »

    Multi-ethnic people looking at camera sitting at public place screaming, shouting and feeling overjoyed about their windfall, good news or sports victory.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX shares finally reversed their losses today.

    Read more »

    A shocked man sits at his desk looking at his laptop while talking on his mobile phone with declining arrows in the background representing falling ASX 200 shares today
    Share Market News

    9 ASX shares including Nuix and PolyNovo dumped from ASX 200

    | Bronwyn Allen

    S&P Dow Jones Indices has revealed which stocks will drop out in the next rebalance.

    Read more »

    A woman with a broad smile on her face holds up ten fingers.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors endured more selling this Tuesday.

    Read more »

    Formula one racing flag being waved in the air.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a decent start to the trading week this Monday.

    Read more »

    Man pointing at a blue rising share price graph.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 opened the trading week with a bang today.

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Broker Notes

    These ASX 200 shares could rise 30% to 50%+

    | James Mickleboro

    Let's see why analysts think these shares could deliver the goods for investors.

    Read more »

    A group of people excitedly cheering at a horse race.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a sobering hump day for investors this session.

    Read more »

    A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
    Share Market News

    'A very special asset': Why this ASX stock could rise 60%+

    | James Mickleboro

    Big returns could be on the cards for buyers of this stock according to Bell Potter.

    Read more »

    CU6 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clarity Pharmaceuticals

    Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

    Profile

    since

    Note